Compare against compounded options
Cai, S., Xie, Y., Bagby, T
5 Figure 3: Pharmacy claims data show that 63% of patients initiating Wegovy or Zepbound in early 2024 remained on therapy at one year, up from 40% in the 2023 cohort
Ro's cost is consultation fee plus branded medication (roughly $250$500/month combined, per published rates verify with Ro)
In order to establish the role of AC metabolism in depression risk, we previously [32] leveraged summary-level data from large GWAS (up to ~800,000 samples) and Mendelian randomization analyses to examine the potential reciprocal relationships between circulating levels of 15 ACs and depression
Learn how routine visits, screenings, and risk review support long-term health